Frontiers in Microbiology (Jun 2020)
The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive Klebsiella pneumoniae in a Multi-Country Collection
- Myeongjin Choi,
- Myeongjin Choi,
- Nicolas Hegerle,
- Nicolas Hegerle,
- Joseph Nkeze,
- Joseph Nkeze,
- Shaichi Sen,
- Shaichi Sen,
- Sanchita Jamindar,
- Sanchita Jamindar,
- Shamima Nasrin,
- Shamima Nasrin,
- Sunil Sen,
- Sunil Sen,
- Jasnehta Permala-Booth,
- Jasnehta Permala-Booth,
- James Sinclair,
- James Sinclair,
- Milagritos D. Tapia,
- Milagritos D. Tapia,
- J. Kristie Johnson,
- Sylla Mamadou,
- Joshua T. Thaden,
- Vance G. Fowler,
- Vance G. Fowler,
- Ana Aguilar,
- Enrique Terán,
- Dominique Decre,
- Florence Morel,
- Karen Angeliki Krogfelt,
- Annelie Brauner,
- Efthymia Protonotariou,
- Eirini Christaki,
- Eirini Christaki,
- Yuichiro Shindo,
- Yi-Tsung Lin,
- Yi-Tsung Lin,
- Andrea L. Kwa,
- Andrea L. Kwa,
- Andrea L. Kwa,
- Sadia Shakoor,
- Ashika Singh-Moodley,
- Olga Perovic,
- Jan Jacobs,
- Jan Jacobs,
- Octavie Lunguya,
- Raphael Simon,
- Raphael Simon,
- Alan S. Cross,
- Alan S. Cross,
- Sharon M. Tennant,
- Sharon M. Tennant
Affiliations
- Myeongjin Choi
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Myeongjin Choi
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Nicolas Hegerle
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Nicolas Hegerle
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Joseph Nkeze
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Joseph Nkeze
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Shaichi Sen
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Shaichi Sen
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Sanchita Jamindar
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Sanchita Jamindar
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Shamima Nasrin
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Shamima Nasrin
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Sunil Sen
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Sunil Sen
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Jasnehta Permala-Booth
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Jasnehta Permala-Booth
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- James Sinclair
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- James Sinclair
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Milagritos D. Tapia
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Milagritos D. Tapia
- Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States
- J. Kristie Johnson
- Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, United States
- Sylla Mamadou
- Centre pour le Développement des Vaccins, Bamako, Mali
- Joshua T. Thaden
- Division of Infectious Diseases, Duke University Medical Center, Durham, NC, United States
- Vance G. Fowler
- Department of Medicine, Division of Infectious Diseases and International Health, Duke University School of Medicine, Durham, NC, United States
- Vance G. Fowler
- Duke Clinical Research Institute, Durham, NC, United States
- Ana Aguilar
- Colegio de Ciencias de la Salud e Instituto de Microbiologia, Universidad San Francisco de Quito, Quito, Ecuador
- Enrique Terán
- Colegio de Ciencias de la Salud e Instituto de Microbiologia, Universidad San Francisco de Quito, Quito, Ecuador
- Dominique Decre
- 0Département de Bactériologie, Centre d’Immunologie et des Maladies Infectieuses-Paris, Cimi-Paris, INSERM U1135, AP-HP, Sorbonne Université, Hôpitaux Universitaires Est Parisien, Paris, France
- Florence Morel
- 0Département de Bactériologie, Centre d’Immunologie et des Maladies Infectieuses-Paris, Cimi-Paris, INSERM U1135, AP-HP, Sorbonne Université, Hôpitaux Universitaires Est Parisien, Paris, France
- Karen Angeliki Krogfelt
- 1Statens Serum Institut, Copenhagen, Denmark
- Annelie Brauner
- 2Department of Microbiology, Tumor and Cell Biology, Division of Clinical Microbiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- Efthymia Protonotariou
- 3Department of Microbiology, AHEPA University Hospital, Thessaloniki, Greece
- Eirini Christaki
- 4Department of Medicine, AHEPA University Hospital, Thessaloniki, Greece
- Eirini Christaki
- 5Medical School, University of Cyprus, Nicosia, Cyprus
- Yuichiro Shindo
- 6Department of Respiratory Medicine, Graduate School of Medicine, Nagoya University, Nagoya, Japan
- Yi-Tsung Lin
- 7Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
- Yi-Tsung Lin
- 8Institute of Emergency and Critical Care Medicine, National Yang-Ming University, Taipei, Taiwan
- Andrea L. Kwa
- 9Department of Pharmacy, Singapore General Hospital, Singapore, Singapore
- Andrea L. Kwa
- 0Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore, Singapore
- Andrea L. Kwa
- 1Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore
- Sadia Shakoor
- 2Departments of Pathology and Pediatrics, Aga Khan University, Karachi, Pakistan
- Ashika Singh-Moodley
- 3National Institute for Communicable Diseases, A Division of the National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Johannesburg, South Africa
- Olga Perovic
- 3National Institute for Communicable Diseases, A Division of the National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Johannesburg, South Africa
- Jan Jacobs
- 4Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium
- Jan Jacobs
- 5Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium
- Octavie Lunguya
- 6Department of Clinical Microbiology and Microbiology, National Institute for Biomedical Research, University Hospital of Kinshasa, Kinshasa, Democratic Republic of Congo
- Raphael Simon
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Raphael Simon
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Alan S. Cross
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Alan S. Cross
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- Sharon M. Tennant
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, United States
- Sharon M. Tennant
- Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States
- DOI
- https://doi.org/10.3389/fmicb.2020.01249
- Journal volume & issue
-
Vol. 11
Abstract
Klebsiella pneumoniae is a common cause of sepsis and is particularly associated with healthcare-associated infections. New strategies are needed to prevent or treat infections due to the emergence of multi-drug resistant K. pneumoniae. The goal of this study was to determine the diversity and distribution of O (lipopolysaccharide) and K (capsular polysaccharide) antigens on a large (>500) global collection of K. pneumoniae strains isolated from blood to inform vaccine development efforts. A total of 645 K. pneumoniae isolates were collected from the blood of patients in 13 countries during 2005–2017. Antibiotic susceptibility was determined using the Kirby-Bauer disk diffusion method. O antigen types including the presence of modified O galactan types were determined by PCR. K types were determined by multiplex PCR and wzi capsular typing. Sequence types of isolates were determined by multilocus sequence typing (MLST) targeting seven housekeeping genes. Among 591 isolates tested for antimicrobial resistance, we observed that 19.3% of isolates were non-susceptible to carbapenems and 62.1% of isolates were multidrug resistant (from as low as 16% in Sweden to 94% in Pakistan). Among 645 isolates, four serotypes, O1, O2, O3, and O5, accounted for 90.1% of K. pneumoniae strains. Serotype O1 was associated with multidrug resistance. Fifty percent of 199 tested O1 and O2 strains were gmlABC-positive, indicating the presence of the modified polysaccharide subunit D-galactan III. The most common K type was K2 by both multiplex PCR and wzi capsular typing. Of 39 strains tested by MLST, 36 strains were assigned to 26 known sequence types of which ST14, ST25, and ST258 were the most common. Given the limited number of O antigen types, diverse K antigen types and the high multidrug resistance, we believe that an O antigen-based vaccine would offer an excellent prophylactic strategy to prevent K. pneumoniae invasive infection.
Keywords